Highlights and Quick Summary
Current Earnings Yield of BioCryst Pharmaceuticals, Inc. is -7.44% (as of December 31, 2021)
- Earnings Yield for the quarter ending September 30, 2022 was -8.33% (a -23.37% decrease compared to previous quarter)
- Year-over-year quarterly Earnings Yield increased by 11.96%
- Annual Earnings Yield for 2021 was -7.44% (a -48.69% decrease from previous year)
- Annual Earnings Yield for 2020 was -14.5% (a -48.96% decrease from previous year)
- Annual Earnings Yield for 2019 was -28.41% (a 134.02% increase from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Earnings Yield of BioCryst Pharmaceuticals, Inc.
Most recent Earnings Yieldof BCRX including historical data for past 10 years.Interactive Chart of Earnings Yield of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Earnings Yield for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -8.33% | -10.87% | -6.58% | – |
| 2021 | -7.44% | -8.84% | -7.59% | -11.8% | -7.44% |
| 2020 | -14.5% | -22.09% | -17.65% | -47.0% | -14.5% |
| 2019 | -28.41% | -42.16% | -31.0% | -12.0% | -28.41% |
| 2018 | -12.14% | -12.76% | -14.64% | -18.44% | -12.14% |
| 2017 | -14.34% | -12.01% | -11.15% | -7.5% | -14.34% |
| 2016 | -11.79% | -21.32% | -34.51% | -24.38% | -11.79% |
| 2015 | -5.72% | -4.39% | -2.81% | -7.97% | -5.72% |
| 2014 | -5.59% | -6.24% | -4.94% | -5.95% | -5.59% |
| 2013 | -7.24% | -9.34% | -45.34% | -54.35% | -7.24% |
| 2012 | -55.63% | -19.95% | -24.38% | -22.13% | -55.63% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology